EA200300770A1 - ANTAGONISTS OF EXCESSING AMINO ACID RECEPTORS - Google Patents

ANTAGONISTS OF EXCESSING AMINO ACID RECEPTORS

Info

Publication number
EA200300770A1
EA200300770A1 EA200300770A EA200300770A EA200300770A1 EA 200300770 A1 EA200300770 A1 EA 200300770A1 EA 200300770 A EA200300770 A EA 200300770A EA 200300770 A EA200300770 A EA 200300770A EA 200300770 A1 EA200300770 A1 EA 200300770A1
Authority
EA
Eurasian Patent Office
Prior art keywords
formula
excessing
antagonists
amino acid
acid receptors
Prior art date
Application number
EA200300770A
Other languages
Russian (ru)
Inventor
Вьен Ван Хау
Майкл Эдвард Летурно
Майкл Джон Мартинелли
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200300770A1 publication Critical patent/EA200300770A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Настоящее изобретение касается новых фармацевтически приемлемых солей соединений формулы I и формулы Ia, а также способов применения фармацевтически приемлемых солей и, кроме того, способов получения соединений формулы I и формулы Ia или их фармацевтически приемлемых солей. Соединения формулы I и формулы Ia могут использоваться для лечения неврологических нарушений, в частности мигрени.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to new pharmaceutically acceptable salts of compounds of formula I and formula Ia, as well as methods of using pharmaceutically acceptable salts and, in addition, methods for preparing compounds of formula I and formula Ia or their pharmaceutically acceptable salts. The compounds of formula I and formula Ia can be used to treat neurological disorders, in particular migraines. The international application was published together with an international search report.

EA200300770A 2001-01-05 2001-12-20 ANTAGONISTS OF EXCESSING AMINO ACID RECEPTORS EA200300770A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26001401P 2001-01-05 2001-01-05
PCT/US2001/044715 WO2002053561A1 (en) 2001-01-05 2001-12-20 Excitatory amino acid receptor antagonists

Publications (1)

Publication Number Publication Date
EA200300770A1 true EA200300770A1 (en) 2003-10-30

Family

ID=22987455

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300770A EA200300770A1 (en) 2001-01-05 2001-12-20 ANTAGONISTS OF EXCESSING AMINO ACID RECEPTORS

Country Status (23)

Country Link
EP (1) EP1351955A1 (en)
JP (1) JP2004520335A (en)
KR (1) KR20030066797A (en)
CN (1) CN1484642A (en)
AR (1) AR035679A1 (en)
BR (1) BR0116672A (en)
CA (1) CA2431545A1 (en)
CZ (1) CZ20031856A3 (en)
DZ (1) DZ3460A1 (en)
EA (1) EA200300770A1 (en)
EC (1) ECSP034682A (en)
HR (1) HRP20030544A2 (en)
HU (1) HUP0302528A2 (en)
IL (1) IL156138A0 (en)
MX (1) MXPA03005981A (en)
NO (1) NO20032973L (en)
NZ (1) NZ525821A (en)
PE (1) PE20020792A1 (en)
PL (1) PL361934A1 (en)
SK (1) SK8242003A3 (en)
TW (1) TW591023B (en)
WO (1) WO2002053561A1 (en)
ZA (1) ZA200304311B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
SK11812000A3 (en) * 1998-02-06 2001-08-06 Smithkline Beecham Plc Salts of paroxetine
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
TR200200066T2 (en) * 1999-07-06 2002-04-22 Eli Lilly And Company Selective iGluR5 receptor antagonists for the treatment of migraine

Also Published As

Publication number Publication date
IL156138A0 (en) 2003-12-23
ZA200304311B (en) 2004-09-02
NO20032973D0 (en) 2003-06-27
EP1351955A1 (en) 2003-10-15
NO20032973L (en) 2003-06-27
CA2431545A1 (en) 2002-07-11
HUP0302528A2 (en) 2003-11-28
BR0116672A (en) 2003-09-23
CZ20031856A3 (en) 2003-09-17
PL361934A1 (en) 2004-10-18
KR20030066797A (en) 2003-08-09
SK8242003A3 (en) 2004-01-08
CN1484642A (en) 2004-03-24
WO2002053561A1 (en) 2002-07-11
JP2004520335A (en) 2004-07-08
ECSP034682A (en) 2003-08-29
DZ3460A1 (en) 2002-07-11
MXPA03005981A (en) 2003-09-10
HRP20030544A2 (en) 2004-08-31
AR035679A1 (en) 2004-06-23
NZ525821A (en) 2004-07-30
TW591023B (en) 2004-06-11
PE20020792A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
EA200300919A1 (en) N-SUBSTITUTED NON-ARYL HETEROCYCLIC ANTAGONISTS NMDA / NR2B
EA200300171A1 (en) CYCLOPENTANOINDOLS, COMPOSITIONS CONTAINING THE COMPONENTS, AND METHODS OF TREATMENT
EA200100971A1 (en) NEW COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS
EA200400595A1 (en) BENZIMIDAZOLY, USED AS PROTEKINKINASE INHIBITORS
EA200401309A1 (en) TRYZE-SUBSTITUTED HETEROARILES AND METHODS OF THEIR RECEPTION AND APPLICATION
EA200200546A1 (en) SUSTAINABLE POLYMORPH OF N- (3-ETHINYLPHENYL) -6,7-BIS HYDROCHLORIDE (2-METHOXYETHOXY) -4-HINAZOLYNAMINE, METHODS FOR ITS PREPARATION AND PHARMACEUTICAL APPLICATIONS
EA200400953A1 (en) SUBSTITUTED PYRIDINOES AS MAP-KINASE P38 MODULATORS
EA200500169A1 (en) SUBSTITUTED DERIVATIVES 1,3-DIPHENYLPROP-2-EN-1-SHE, RECEIVING AND APPLICATION
EA200100748A1 (en) MONOAMINE RETURN INHIBITORS FOR THE TREATMENT OF CNS DISORDERS
EA200500342A1 (en) HETEROCYCLIC SUBSTITUTED PIPERASINES FOR THE TREATMENT OF SCHIZOPHRENIA
EA200300528A1 (en) 1-ARYL-OR 1-ALKYLSULPHONYLETHETROCYCLYLBENZAZOLES AS LIGANDS 5-HYDROXITRIPTAMINE-6
EA200500814A1 (en) DERIVATIVES OF PYRROPOLYMIDININE
EA200400073A1 (en) Pyrrolipyrimins as inhibitors of protein kinases
EA200300211A1 (en) AZABICCAL COMPOUNDS, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS A MEDICINE, IN PARTICULAR AS ANTIBACTERIAL MEANS
EA200400892A1 (en) DERIVATIVES NICOTINAMIDA USEFUL AS PDE4 INHIBITORS
EA200100203A1 (en) DERIVATIVES 4,4-BIARILPIPERIDIN WITH ACTIVITY WITH RESPECT TO OPIOID RECEPTORS
EA200301306A1 (en) DERIVATIVES 1-PHENYLSULFONIL-1,3-DIHYDRO-2H-INDOL-2-SHE, THEIR PRODUCTION AND THEIR THERAPEUTIC APPLICATION
EA200800760A1 (en) PYRIDOPYRIMIDINONE INHIBITORS PI3Kα
EA200501274A1 (en) PYRAZOLES AND METHODS FOR THEIR PRODUCTION AND APPLICATION
EA200201179A1 (en) DERIVATIVES 2-AMINOKARBONIL-9H-PURINA
EA200300829A1 (en) Derivatives of 1-aryl-or 1-alkylsulfonylbenzene as a ligand 5-hydroxytriptamine-6
EA200300527A1 (en) NEW TREATMENT METHODS FOR TIRED FOOT SYNDROME
EA200300619A1 (en) SEROTONINERGIC MEANS
EA200300424A1 (en) SALTS OF ISOTHIAZOLE-4-CARBOXAMIDE AND THEIR APPLICATION AS ANTIHYPERPROLIFERATIVE AGENTS
EA200970192A1 (en) DERIVATIVES 5,6-BISARIL-2-PYRIDIN-CARBOXAMIDE, THEIR RECEIVING AND THEIR APPLICATION IN THERAPY AS ANTAGONISTS OF UROTENZIN II RECEPTORS